A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Public ClinicalTrials.gov record NCT05650632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Phase 1b, Open-label Study to Evaluate Dose Optimization Measures and Safety of Etentamig (ABBV-383) in Subjects With Relapsed or Refractory Multiple Myeloma
Study identification
- NCT ID
- NCT05650632
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 210 participants
Conditions and interventions
Conditions
Interventions
- Etentamig (ABBV-383) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 20, 2023
- Primary completion
- Jul 31, 2029
- Completion
- Jul 31, 2029
- Last update posted
- Feb 11, 2026
2023 – 2029
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona /ID# 251405 | Phoenix | Arizona | 85054 | Recruiting |
| Highlands Oncology Group - Springdale /ID# 267742 | Springdale | Arkansas | 72762 | Recruiting |
| Rocky Mountain Cancer Centers - Aurora /ID# 268574 | Aurora | Colorado | 80012 | Recruiting |
| Medical Oncology Hematology Consultants /ID# 268560 | Newark | Delaware | 19713 | Recruiting |
| Hope And Healing Cancer Services /ID# 268536 | Hinsdale | Illinois | 60521 | Recruiting |
| Fort Wayne Medical Oncology And Hematology /ID# 268179 | Fort Wayne | Indiana | 46804 | Recruiting |
| Tulane University School of Medicine /ID# 251204 | New Orleans | Louisiana | 70112 | Recruiting |
| Mayo Clinic - Rochester /ID# 251164 | Rochester | Minnesota | 55905-0001 | Recruiting |
| NHO Revive Research Institute, LLC /ID# 267869 | Lincoln | Nebraska | 68506 | Recruiting |
| Mt Sinai /ID# 251166 | New York | New York | 10029-6542 | Recruiting |
| Memorial Sloan Kettering Cancer Center-Koch Center /ID# 251167 | New York | New York | 10065-6007 | Recruiting |
| University of North Carolina /ID# 251203 | Chapel Hill | North Carolina | 27514 | Recruiting |
| Atrium Health Wake Forest Baptist Medical Center /ID# 251165 | Winston-Salem | North Carolina | 27157 | Recruiting |
| University Of Cincinnati Medical Center /ID# 251746 | Cincinnati | Ohio | 45219 | Recruiting |
| Willamette Valley Cancer Institute and Research Center /ID# 267088 | Eugene | Oregon | 97401 | Recruiting |
| Vanderbilt Ingram Cancer Center /ID# 252470 | Nashville | Tennessee | 37232-0021 | Recruiting |
| Texas Oncology - Central/South Texas /ID# 268563 | Austin | Texas | 78705 | Recruiting |
| Oncology Consultants /ID# 268323 | Houston | Texas | 77030 | Recruiting |
| Texas Oncology - Northeast Texas /ID# 268877 | Tyler | Texas | 75702 | Recruiting |
| Virginia Cancer Specialists - Fairfax /ID# 268559 | Fairfax | Virginia | 22031 | Recruiting |
| Fred Hutchinson Cancer Center. /ID# 267940 | Seattle | Washington | 98109-4405 | Recruiting |
| Northwest Medical Specialties Tacoma /ID# 267117 | Tacoma | Washington | 98405 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05650632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2026 · Synced May 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05650632 live on ClinicalTrials.gov.